Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Osborn, David A ^a   Hunt, R W ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

Humans; Infant, newborn; Infant, premature *blood ; Thyroid diseases blood; drug therapy ; Thyroid hormones *therapeutic use ; Thyroxine *blood

Indexed keywords

PLACEBO; THYROTROPIN; THYROXINE;

BODY HEIGHT; BRAIN DEVELOPMENT; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; EMBASE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MEDLINE; NECROTIZING ENTERITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; REVIEW; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WEIGHT GAIN;

EID: 42449090704     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005945.pub2     Document Type: Review

References (58)

1. Chowdhry 1984 {published and unpublished data} Chowdhry P, Scanlon JW, Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984;73:301-5.
2. Amato 1988 Amato M, Pasquier S, Carasso A, Von Muralt G. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants. Hormone Research 1988;29:27-30.
3. Amato 1989 Amato M, Guggisberg C, Schneider H. Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant. Hormone Research 1989;32(5-6):213-7.
4. Bettendorf 2000 Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000;356:529-34.
5. Biswas 2003 Biswas S, Buffery J, Enoch H, Bland JM, Walters D, Markiewicz M. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-7.
6. *Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial - thyroid hormone replacement in neonates. Pediatric Research 2003;53:48-56.
7. Cassio A 2003 Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E, Balsamo A, Bal M, Gualandi S. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine?. Pediatrics 2003;111:1055-60.
8. Chowdhury 2001 Chowdhury D, Ojamaa K, Parnell VA, McMahon C, Sison CP, Klein I. A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. Journal of Thoracic & Cardiovascular Surgery 2001;122:1023-5.
9. Eggermont 1984 Eggermont E, Vanderschueren Lodeweyckx M, De Nayer P, Smeets E, Vanacker G, Cornette C, Jaeken J, Devlieger H, Eeckels R, Beckers C. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: evidence for a "transient lazy thyroid system". Helvetica Paediatrica Acta 1984;39:209-22.
10. Schonberger 1981 Schonberger W, Grimm W, Emmrich P, Gempp W. Reduction of mortality rate in premature infants by substitution of thyroid hormones. European Journal of Pediatrics 1981;135:245-53.
11. Selva 2002 Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, Nelson JC, Lafranchi SH. Initial treatment dose of L-thyroxine in congenital hypothyroidism. Journal of Pediatrics 2002;141:786-92.
12. Smith 2000 Smith LM, Leake RD, Berman N, Villanueva S, Brasel JA. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. Journal of Perinatology 2000;20:427-31.
13. Valerio 2004 *Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatric Research 2004;55:248-53.
14. Valerio PG, van Wassenaer AG, Kok JH. A randomized, masked study of T3 plus T4 administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatric Research. 2002; Vol. 51:125A.
15. van Wassenaer 1993 van Wassenaer AG, Kok JH, Endert E, Vulsma T, de Vijlder JJ. Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinologica 1993;129:139-46.
16. van Wassenaer 1997 Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-8.
17. Briet JM, van Wassenaer AG, van Baar A, Dekker FW, Kok JH. Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants. Developmental Medicine and Child Neurology 1999;41:87-93.
18. Smit BJ, Kok JH, de Vries LS, van Wassenaer AG, Dekker FW, Ongerboer de Visser BW. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation. Journal of Pediatrics 1998;132:64-9.
19. Smit BJ, Kok JH, de Vries LS, van Wassenaer AG, Dekker FW, Ongerboer de Visser BW. Somatosensory evoked potentials in very preterminfants in relation to L-thyroxine supplementation. Pediatrics 1998;101:865-9.
20. van Wassenaer, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatric Research 1997;42:604-9.
21. van Wassenaer AG, Briët JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJM, Kok JH. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;109:534-9.
22. Van Wassenaer AG, Kok JH, Briet JM, Pijning AM, de Vijlder JJ. Thyroid function in very preterm newborns: possible implications. Thyroid 1999;9(85-91).
23. van Wassenaer AG, Kok JH, Briet JM, van Baar A, de Vijlder JJ. Thyroid function in preterm newborns; is T4 treatment required in infants <27 weeks' gestational age?. Experimental and Clinical Endocrinology & Diabetes 1997;105:12-8.
24. van Wassenaer AG, Kok JH, Dekker FW, Endert E, de Vijlder JJ. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations. European Journal of Endocrinology 1998;139:508-15.
25. *van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P, van Baar A, Dekker FW, Vulsma T. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. The New England Journal of Medicine 1997;336:21-6.
26. Vanhole 1997 Vanhole C, Aerssens P, Devlieger H, de Zegher F. L-Thyroxine treatment of preterm newborns. Pediatric Research 1996;40:555.
27. *Vanhole C, Aerssens P, Naulaers G, Casneuf A, Devlieger H, Van den Berghe G, de Zegher F. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatric Research 1997;42:87-92.
28. Golombek Hypothyroxemia trial. Ongoing study To be announced.
29. Ballabio 1989 Ballabio M, Nicolini U, Jowett T, Ruiz de Elvira MC, Ekins RP, Rodeck CH. Maturation of thyroid function in normal human foetuses. Clinical Endocrinology 1989;31:565-71.
30. Belet 2003 Belet N, Imdat H, Yanik F, Kucukoduk S. Thyroid function tests in preterm infants born to preeclamptic mothers with placental insufficiency. Journal of Pediatric Endocrinology 2003;16:1131-5.
31. Beranl 1995 Beranl J, Nunez J. Thyroid hormones and brain development. European Journal of Endocrinology 1995;133:390-8.
32. Den Ouden 1996 Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatric Research 1996;39:142-5.
33. Filippi 2004 Filippi L, Cecchi A, Tronchin M, Dani C, Pezzati M, Seminara S, et al.Dopamine infusion and hypothyroxinaemia in very low birth weight preterm infants. European Journal of Pediatrics 2004;163:7-13.
34. Frank 1996 Frank JE, Faix JE, Hermos RJ, Mullaney DM, Rojan DA, Mitchell ML, et al.Thyroid function in very low birth weight infants: effects on hypothyroidism screening. Journal of Pediatrics 1996;128:548-54.
35. Franklin 1986 Franklin RC, Purdie GL, O'Grady CM. Neonatal thyroid function: prematurity, prenatal steroids, and respiratory distress syndrome. Archives of Disease in Childhood 1986;61:589-92.
36. Hsu 1999 Hsu CH, Chang JH, Lee YJ, Hung HY, Kao HA, Huang FY. Thyroid function in the sick very low-birth-weight infants. Acta Paediatrica Taiwanica 1999;40:237-42.
37. Kantor Herring 2003 Kantor Herring MJ, Leef KH, Locke RG, Stefano JL, Bartoshesky L, Paul DA. Are perinatal risk factors helpful in predicting and optimizing treatment strategies for transient hypothyroxinemia in very-low-birth-weight infants?. American Journal of Perinatology 2003;20:333-9.
38. Kooistra 1994 Kooistra L, Laane C, Vulsma T, Schellekens JMH, van derMeere JJ, Kalverboer AF. Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. Journal of Pediatrics 1994;124:903-9.
39. Linder 1997 Linder N, Davidovitch N, Reichman B, Kuint J, Lubin D, Meyerovitch J, et al.Topical iodine-containing antiseptics and subclinical hypothyroidismin preterminfants. Journal of Pediatrics 1997;131:434-9.
40. Lorenz 1998 Lorenz JM, Wooliever DE, Jetton JR, Paneth N. A quantitative review of mortality and developmental disability in extremely premature newborns. Archives of Pediatric and Adolescent Medicine 1998;152:425-35.
41. Lucas 1988 Lucas A, Rennie J, Baker BA, Morley R. Low plasma triiodothyronine and outcome in preterm infants. Archives of Disease in Childhood 1988;63:1201-6.
42. Lucas 1996 Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. British Medical Journal 1996;312:1132-3.
43. Meijer 1992 Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL. Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Archives of Disease in Childhood 1992;67:944-7.
44. Osborn 2007a Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD005948. DOI:10.1002/14651858.CD005948.pub2.
45. Osborn 2007b Osborn DA, Hunt RW. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD005946. DOI:10.1002/14651858. CD005946.pub2.
46. Paneth 1998 Paneth N. Does transient thyroxinemia cause abnormal neurodevelopment in premature infants?. Clinics in Perinatology 1998;25:627-43.
47. Paul 1998 Paul DA, Leef KH, Stefano JL, Bartoshesky L. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics 1998;101:903-7.
48. Paul 2000 Paul DA, Leef KH, Stefano JL, Bartoshesky L. Thyroid function in very-low-birth-weight infants with intraventricular hemorrhage. Clinics in Pediatrics 2000;39:651-6.
49. Porterfield 1993 Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development - current perspectives. Endocrine Reviews 1993;14:94-106.
50. Radunovic 1991 Radunovic N, Dumez Y, Nastic D, Mandelbrot L, Dommergues M. Thyroid function in fetus and mother during the second half of normal pregnancy. Biology of the Neonate 1991;59:139-48.
51. Reuss 1996 Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. New England Journal of Medicine 1996;334:821-7.
52. Reuss 1997 Reuss ML, Leviton A, Paneth N, Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. American Journal of Public Health 1997;87:1693-7.
53. Rooman 1996 Rooman RP, Du Caju MVL, De Beeck LO, Docx M, Van Reempts P, Van Acker KJ. Low thyroxinaemia occurs in the majority of very preterm newborns. European Journal of Pediatrics 1996;155:211-5.
54. Tahirovic 1994 Tahirovic HF. Transient hypothyroxinemia in neonates with birth asphyxia delivered by emergency cesarean section. Journal of Pediatric Endocrinology 1994;7:39-41.
55. Thorpe-Beeston 1991 Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM. Maturation of the secretion of thyroid hormone and thyroid stimulating hormone in the fetus. New England Journal of Medicine 1991;324:532-6.
56. Uhrmann 1981 Uhrmann S, Marks KH, Maisels MJ, Kulin HE, Kaplan M, Utiger R. Frequency of transient hypothyroxinaemia in low birthweight infants. Potential pitfall for neonatal screening programmes. Archives of Disease in Childhood 1981;56:214-7.
57. van Wassenaer 1997 van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatric Research 1997;42:604-9.
58. van Wassenaer 2004 van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Seminars in Neonatology 2004;9:3-11.